Transaction Details:

Hash 10930ff6d1fd0f090e2c27935101f91c3b442eccc37a95af0160b23b89859045
Blockhash 2a3fdb49be336b797739ae8e4e8d6c05960e25a630152e0933b7ac26fc558ea8
Blocktime 2019-11-22 17:51
Confirmations 45529

Inputs

Index Previous Output Address
0 1db1cd1f20c4e9e3f1831234cb3b4c8468193f3e9d767c1ed58c08a73fd16fa7:0 2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd

Outputs

Index Redeemed in Address Amount
0 Not yet redeemed N/A 0 CBL
1 Not yet redeemed 2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd 99.99982708 CBL
{
"txid": 10930ff6d1fd0f090e2c27935101f91c3b442eccc37a95af0160b23b89859045,
"time": 1574445110,
"blocktime": 1574445110,
"blockhash": 2a3fdb49be336b797739ae8e4e8d6c05960e25a630152e0933b7ac26fc558ea8,
"confirmations": 45529,
"vin ": [
{
"vout": 0
"txid": 1db1cd1f20c4e9e3f1831234cb3b4c8468193f3e9d767c1ed58c08a73fd16fa7
"scriptSig": {'hex': '4830450221009795a254dec9a2ec31df664adb9e0745160526a341399f6276df143be95cdc9e0220781e628718e919d983453e10ec64b651e04b0dbd88d01c50bfa23260f843a629012103f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38', 'asm': '30450221009795a254dec9a2ec31df664adb9e0745160526a341399f6276df143be95cdc9e0220781e628718e919d983453e10ec64b651e04b0dbd88d01c50bfa23260f843a62901 03f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38'}
"sequence": 4294967295
}
],
"vout ": [
{
"value": 0
"items": [
{'type': 'stream', 'name': 'iscc', 'streamref': '22580-300-49565', 'data': {'json': {'title': 'development of tumor targeting bioprobes 111inchimeric l6 monoclonal antibody nanoparticles for alternating magnetic field cance', 'meta': [{'schema': 'schema.org', 'data': {'identifier': [{'propertyID': 'DOI', 'value': '10.1158/1078-0432.ccr-1004-0022', '@type': 'PropertyValue'}, {'propertyID': 'ISCC', 'value': 'CCar4oDtPfbN2-CTPZNRyCVjSy9-CDD9vGNmgifS8-CREBsAjqeyGnd', '@type': 'PropertyValue'}], 'datePublished': '2005-10-01', 'publisher': {'name': 'American Association for Cancer Research (AACR)', '@type': 'Organization'}, 'name': 'Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy', '@type': 'ScholarlyArticle', 'genre': 'journal-article', 'author': [{'name': 'S. J. DeNardo', '@type': 'Person'}], 'encoding': [{'contentUrl': 'http://clincancerres.aacrjournals.org/content/clincanres/11/19/7087s.full.pdf', '@type': 'MediaObject', 'encodingFormat': 'application/pdf'}], '@context': 'http://schema.org/'}, 'mediatype': 'application/ld+json'}], 'tophash': '4ed79b4fe134f1a2f798854d1e67ecfd927275d834681d2ad992714e57871292'}}, 'keys': ['CCar4oDtPfbN2', 'CTPZNRyCVjSy9', 'CDD9vGNmgifS8', 'CREBsAjqeyGnd'], 'publishers': ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd'], 'createtxid': '9dc120f0f3ba1bf3cc53010a0af74f164961f37595bdd9a89b5064e60304c070'}
],
"n": 0
"scriptPubKey": {
"hex": 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
"type": nulldata
"asm": 73706b65164ff70a0a0153ccf31bbaf3f020c19d OP_DROP 73706b6b43436172346f44745066624e32 OP_DROP 73706b6b4354505a4e527943566a537939 OP_DROP 73706b6b4344443976474e6d6769665338 OP_DROP 73706b6b4352454273416a716579476e64 OP_DROP 73706b6602 OP_DROP OP_RETURN 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
}
},
{
"value": 99.99982708
"n": 1
"scriptPubKey": {
"hex": 76a91470f3924b82ad8ba9ca4b38ee85a83bd99c142f9f88ac
"type": pubkeyhash
"addresses": ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd']
"asm": OP_DUP OP_HASH160 70f3924b82ad8ba9ca4b38ee85a83bd99c142f9f OP_EQUALVERIFY OP_CHECKSIG
"reqSigs": 1
}
}
]
}